ERAS Protocols Improve Patient Outcomes and Reduce Opioid Use
The ERAS Protocols Improve Patient Outcomes and Reduce Opioid Use course was presented at the American College of Surgeons Clinical Congress 2017 as part of a larger panel session focused on surgical perioperative strategies to reduce opioid consumption while maintaining safe and effective pain control.
In this course, Thomas Aloia, MD, FACS, shares his best practices for implementing an opioid-sparing protocol during his patients' hepatectomies.
The ERAS Protocols Improve Patient Outcomes and Reduce Opioid Use course, offered by the American College of Surgeons Division of Education, is intended for use only by the course participant. Thank you in advance for your participation.
Illustrate how enhanced recovery protocols can be used to improve patient outcomes and decrease the need for postsurgical opioids.
- ERAS Protocols Improve Patient Outcomes and Reduce Opioid Use
- Sample Enhanced Recovery After Surgery (ERAS) Protocol
- Course Evaluation
- Practicing surgeons
- Professional health care providers
If you have any questions about this course, please contact email@example.com.
For technical assistance, please contact firstname.lastname@example.org.
Faculty and Disclosures
Thomas A. Aloia, MD
Associate Professor of Surgical Oncology
Division of Surgery, Director of Quality and Outcomes
MD Anderson Cancer Center
In accordance with the ACCME’s Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity has disclosed all relevant financial relationships with any commercial interest. Therefore, it is mandatory that both the program planning committee and speakers complete disclosure forms. Members of the program committee were required to disclose all financial relationships and speakers were required to disclose any financial relationship as it pertains to the content of the presentations. The ACCME defines a ‘commercial interest’ as “any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.” It does not consider providers of clinical service directly to patients to be commercial interests. The ACCME considers “relevant” financial relationships as financial transactions (in any amount) that may create a conflict of interest and occur within the 12 months preceding the time that the individual is being asked to assume a role controlling content of the educational activity.
The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the presentation. The planning committee members and speakers were contacted and the conflicts listed below have been managed to our satisfaction. However, if you perceive a bias, please advise us of the circumstances on the evaluation form.
Please note we have advised the speakers that it is their responsibility to disclose at the start of their presentation if they will be describing the use of a device, product, or drug that is not FDA approved or the off-label use of an approved device, product, or drug or unapproved usage.
The requirement for disclosure is not intended to imply any impropriety of such relationships, but simply to identify such relationships through full disclosure, and to allow the audience to form its own judgments regarding the presentation.
- 0.50 AMA PRA Category 1 Credit™